Affordable Access

Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment.

Authors
Type
Published Article
Journal
Clinical Oncology
0936-6555
Publisher
Elsevier
Publication Date
Volume
11
Issue
5
Pages
340–347
Identifiers
PMID: 10591823
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments